Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Asset Utilization Ratio (2023 - 2025)

Historic Asset Utilization Ratio for Iovance Biotherapeutics (IOVA) over the last 6 years, with Q3 2025 value amounting to 0.28.

  • Iovance Biotherapeutics' Asset Utilization Ratio changed N/A to 0.28 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28, marking a year-over-year change of. This contributed to the annual value of 0.19 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Iovance Biotherapeutics' Asset Utilization Ratio is 0.28.
  • Over the past 5 years, Iovance Biotherapeutics' Asset Utilization Ratio peaked at 0.28 during Q3 2025, and registered a low of 0.0 during Q2 2023.
  • In the last 3 years, Iovance Biotherapeutics' Asset Utilization Ratio had a median value of 0.0 in 2024 and averaged 0.11.
  • The largest annual percentage gain for Iovance Biotherapeutics' Asset Utilization Ratio in the last 5 years was 971943.66% (2025), contrasted with its biggest fall of 971943.66% (2025).
  • Over the past 3 years, Iovance Biotherapeutics' Asset Utilization Ratio (Quarter) stood at 0.0 in 2023, then soared by 58.43% to 0.0 in 2024, then soared by 11875.45% to 0.28 in 2025.
  • Its Asset Utilization Ratio stands at 0.28 for Q3 2025, versus 0.26 for Q2 2025 and 0.23 for Q1 2025.